Displaying results 1 - 12 of 26
Public Health and Advocacy
EASL Policy Dialogues Episode 2: The liver, alcohol, and politics

EASL Policy Dialogues Episode 2: The liver, alcohol, and politics

EASL Policy Dialogues
View
General Hepatology
EASL Studio S3 E5: JHEP Live: Stigma and alcohol

EASL Studio S3 E5: JHEP Live: Stigma and alcohol

EASL Studio
View
Viral Hepatitis
EASL Studio Special Edition: Live from Viral Hepatitis Elimination Conference 2022

EASL Studio Special Edition: Live from Viral Hepatitis Elimination Conference 2022

EASL Studio
View
COVID-19 and the liver
EASL Policy Statement on the Use of COVID-19 Vaccines in People with Chronic Liver Disease, Hepatobiliary Cancer, and Liver Transplant Recipients

EASL Policy Statement on the Use of COVID-19 Vaccines in People with Chronic Liver Disease, Hepatobiliary Cancer, and Liver Tr...

PDF
View
Public Health and Advocacy
EASL Policy Statement on Liver Cancer Screening

EASL Policy Statement on Liver Cancer Screening

PDF
View
Public Health and Advocacy
EASL Policy Dialogues Episode 1: Drug use, viral hepatitis, and Europe

EASL Policy Dialogues Episode 1: Drug use, viral hepatitis, and Europe

EASL Policy Dialogues
View
Public Health and Advocacy
EASL Policy Dialogues Episode 3: Liver cancer: The risk of ignorance

EASL Policy Dialogues Episode 3: Liver cancer: The risk of ignorance

EASL Policy Dialogues
View
Liver Tumours
EASL Studio S1 E1: Liver Cancer Awareness Month

EASL Studio S1 E1: Liver Cancer Awareness Month

EASL Studio
View
Metabolism, Alcohol & Toxicity

Introduction and presentation of the NAFLD patient guideline

Webcasts
View
Metabolism, Alcohol & Toxicity

The user perspective

Webcasts
View
Metabolism, Alcohol & Toxicity

Changing the models of care

Webcasts
View
Metabolism, Alcohol & Toxicity

A practical example from the guideline

Webcasts
View
Displaying results 1 - 12 of 26